Ipsen SA Cash & Equivalents Growth & History (IPN)
Ipsen SA's cash and equivalents was €1.53B for fiscal 2025.
View full Ipsen SA company overviewIpsen SA annual cash and equivalents history
| Fiscal year | Period ended | Cash and equivalents | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €1.53B | €847.4M | +124.97% |
| 2024 | 2024-12-31 | €678.1M | €149.7M | +28.33% |
| 2023 | 2023-12-31 | €528.4M | −€640.9M | −54.81% |
| 2022 | 2022-12-31 | €1.17B | €354.6M | +43.53% |
| 2021 | 2021-12-31 | €814.7M | €172.2M | +26.80% |
| 2020 | 2020-12-31 | €642.5M | — | — |
Ipsen SA quarterly cash and equivalents
| Fiscal quarter | Period ended | Cash and equivalents | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €1.97B | €525.3M | +36.35% |
| Q4 2025 | 2025-12-31 | €1.53B | €847.4M | +124.97% |
| Q2 2025 | 2025-06-30 | €1.45B | — | — |
| Q4 2024 | 2024-12-31 | €678.1M | — | — |
Ipsen SA cash and equivalents trends
Over the last five fiscal years, Ipsen SA's cash and equivalents increased from €642.5M to €1.53B, a change of €883.0M. The latest reported quarter, Q2 2026, shows €1.97B.
What cash and equivalents mean
Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.
Reported cash and equivalents
TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ipsen SA source filings ↗Community posts
Ipsen lifts annual growth and margin forecasts after strong drug sales
Ipsen ($IPN) raised its 2026 sales-growth target to approximately 23% at constant exchange rates, from more than 20%, and its core operating-margin forecast to around 39%, from above 37%. Third-quarter revenue reached €1.17 billion, increas ...